Cargando…
In Vitro/Vivo Activity of Potential MCR-1 Inhibitor in Combination With Colistin Againsts mcr-1-Positive Klebsiella pneumonia
Carbapenem resistance among strains of the nosocomial pathogen Klebsiella pneumoniae is increasing worldwide, causing serious clinical infections and higher mortality rates. Polymyxins are some of the few “last resort” options for treatment of carbapenem-resistant Enterobacteriaceae, including K. pn...
Autores principales: | Zhou, Yonglin, Wang, Tingting, Guo, Yan, Liu, Shui, Wang, Jianfeng, Shen, Yingbo, Tang, Shusheng, Wang, Yang, Deng, Xuming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057107/ https://www.ncbi.nlm.nih.gov/pubmed/30065720 http://dx.doi.org/10.3389/fmicb.2018.01615 |
Ejemplares similares
-
Impact of mcr-1 on the Development of High Level Colistin Resistance in Klebsiella pneumoniae and Escherichia coli
por: Zhu, Xiao-Qing, et al.
Publicado: (2021) -
mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France
por: Caspar, Yvan, et al.
Publicado: (2017) -
Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt
por: Abozahra, Rania, et al.
Publicado: (2023) -
Pogostone Enhances the Antibacterial Activity of Colistin against MCR-1-Positive Bacteria by Inhibiting the Biological Function of MCR-1
por: Xie, Shengnan, et al.
Publicado: (2022) -
Molecular Epidemiology and Colistin Resistant Mechanism of mcr-Positive and mcr-Negative Clinical Isolated Escherichia coli
por: Luo, Qixia, et al.
Publicado: (2017)